MarketCap
Insulet Corporation PODD
€ 143.32
3.08%
Facebook
X
Telegram
Insulet Corporation Kurzfristige Verbindlichkeiten | PODD
Kurzfristige Verbindlichkeiten Jährlich Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 680 M | 528 M | 451 M | 365 M | 229 M | 208 M | 158 M | 116 M | 86 M | 55.7 M | 65.2 M | 44.3 M | 42.4 M | 48.3 M | 28 M | 19 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 680 M | 19 M | 195 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 5.6 | -2.78 % | $ 67 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Outset Medical
OM
|
37.6 M | $ 4.04 | -4.49 % | $ 61.5 K | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 39.49 | -0.6 % | $ 1.82 B | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Quanterix Corporation
QTRX
|
74.8 M | $ 3.67 | -6.38 % | $ 156 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 60.45 | -2.74 % | $ 9.18 B | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 1.42 | -6.58 % | $ 3.94 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
TELA Bio
TELA
|
18 M | $ 0.69 | -2.81 % | $ 32.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Tactile Systems Technology
TCMD
|
41 M | $ 27.48 | 0.15 % | $ 629 M | USA |
 |
TransMedics Group
TMDX
|
89.3 M | $ 72.26 | 1.59 % | $ 2.46 B | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 0.89 | -3.38 % | $ 15.1 M | USA |
 |
Tandem Diabetes Care
TNDM
|
243 M | $ 17.12 | 1.3 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 14.12 | -2.55 % | $ 400 M | USA |
 |
Viemed Healthcare
VMD
|
41.1 M | $ 11.77 | 0.86 % | $ 458 M | USA |
 |
Avanos Medical
AVNS
|
165 M | $ 24.99 | 0.04 % | $ 1.16 B | USA |
 |
Beyond Air
XAIR
|
6.51 M | $ 5.16 | -5.67 % | $ 42.8 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
29.5 M | $ 0.43 | -0.39 % | $ 60 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.36 | -0.39 % | $ 22.4 M | USA |
 |
NanoVibronix
NAOV
|
6.66 M | - | - | $ 1.08 M | USA |
 |
NuVasive
NUVA
|
716 M | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
115 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
103 M | - | - | $ 217 M | USA |
 |
Inogen
INGN
|
63.5 M | $ 6.15 | -2.69 % | $ 164 M | USA |